Cardiovascular Outcomes of GLP-1 Receptor Agonists in Type 2 Diabetes

This presentation explores GLP-1 receptor agonists, focusing on their mechanisms in Type 2 diabetes and cardiovascular health. It reviews cardiovascular outcomes such as heart disease risk reduction, stroke prevention, and hypertension mitigation. Using analytics, clinical trial data and statistical analyses highlight their effectiveness. Implementation strategies for diabetic care plans, patient adherence, and clinical guidelines are discussed. The session concludes with key insights, future...